I am a relatively new investor in this share - OSL has the ability to have a world-wide market income of over $3B is outstanding giving the gross value per share of around $4.66. If this radiation device continues to deliver sound clinical trials OncoSil shares prices will have upward movement, firstly to the previous highs of .20 cents and then beyond. It obviously will have useage in other areas of cancer where the radium can be targeted direct without harming other organs/body parts. Good news all round if it can deliver the treatment direct and increase life for cancer sufferers.
Ann: OncoSil files for TGA registration, page-6
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.001(9.09%) |
Mkt cap ! $45.40M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $18.92K | 1.705M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 13619110 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 5063491 | 9 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| OSL (ASX) Chart |